Heartburn medication recalled over contamination
Drugmaker Sandoz is recalling a heartburn medication in the U.S. due to contamination with NDMA, a possible carcinogen.
The medication is Ranitidine Hydrochloride.
It comes in 150 and 300 milligram capsules and in 30, 60 and 500 count bottles.
Sandoz says it has not gotten any reports of adverse events related to the product contamination.
Its parent company, Novartis, said last week it was stopping distribution of all Ranitidine.
Novartis called the move “precautionary.”
Another company, Sanofi, that makes Ranitdine medication sold under the brand name Zantac.
The company said in a statement last week it had “no plans to stop distributing or manufacturing Zantac or other Ranitidine products outside of Canada.”